Skip to main content
All lobbying filings

AMERICAN ORTHOTIC & PROSTHETIC ASSOCIATION

Lobbying for AMERICAN ORTHOTIC & PROSTHETIC ASSOCIATION

 Filing · LD-2 quarterly report Q3 report
Reporting period
3rd Quarter 2026
July 1 - Sep 30 · Posted Oct 20, 2026
Expenses
$30,000
What this organization spent lobbying with its own staff. Reported using the LDA's own definitions (method A): the three LDA methods count different costs, so an expenses figure is not comparable across filers that used different ones.
Client based in
Virginia

Official filing document

 Government bodies contacted 3

The chambers, agencies and offices the filer named. It does not say who inside them was contacted, or when. Each name opens every filing that named the same body.

 Lobbying activity 4

Legislation and regulation that may impact the practice and/or the profession of orthotics and prosthetics; Issues pertaining to Medicare competitive bidding including an exemption for orthotists and prosthetists; Medicare regulations in regards to the reasonable useful lifetime of orthoses; Medicare fraud and abuse especially the elimination of drop shipping of OTS orthoses, and limiting the elimination/lowering of Medicaid access, to remove select HCPCS codes from the next round of competitive bidding. Specific bills include the Medicare Orthotics and Prosthetics Patient-Centered Care Act (H.R 4475, S.2329).

Veteran and military-connected health care legislation and regulation that may impact the practice and/or delivery of orthotics and/or prosthetics, including the delivery of activity specific devices; and the reestablishment of specific funding for orthotics and prosthetic outcomes research under the OPORP.

Medicare Orthotics and Prosthetics Patient-Centered Care Act(H.R 4475, S.2329). Legislation and regulation that may impact the practice and/or the profession of orthotics and prosthetics. These issues include health insurance coverage issues, managed care, Medicare reform, fraud and abuse, reasonable useful lifetime (RUL) restrictions, and FDA issues (no specific bills). Having TRICARE provide coverage for cranial remolding orthoses.

To Reinstate funding for the Orthotics and Prosthetics Outcomes Research Program (OPORP) as a stand-alone program and to identify O&P Research as an eligible funding category in the Peer-Reviewed Medical Research Program (PRMRP). Funding for the National Limb Loss Resource Center.

 Bills named in this filing 2
  • H.R. 4475
    Medicare Orthotics and Prosthetics Patient-Centered Care Act
  • S. 2329
    Medicare Orthotics and Prosthetics Patient-Centered Care Act

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.

Report a problem